Your browser doesn't support javascript.
loading
Rationale and design of the AXIOMATIC-SSP phase II trial: Antithrombotic treatment with factor XIa inhibition to Optimize Management of Acute Thromboembolic events for Secondary Stroke Prevention.
Sharma, Mukul; Molina, Carlos A; Toyoda, Kazunori; Bereczki, Daniel; Kasner, Scott E; Lutsep, Helmi L; Tsivgoulis, Georgios; Ntaios, George; Czlonkowska, Anna; Shuaib, Ashfaq; Amarenco, Pierre; Endres, Matthias; Diener, Hans Christoph; Gailani, David; Kahl, Anja; Donovan, Mark; Perera, Vidya; Li, Danshi; Hankey, Graeme J.
Afiliación
  • Sharma M; Population Health Research Institute, McMaster University, Hamilton, Ontario, Canada. Electronic address: mike.sharma@phri.ca.
  • Molina CA; Hospital Universitari Vall d´Hebron, Barcelona, Spain.
  • Toyoda K; National Cerebral and Cardiovascular Center, Osaka, Japan.
  • Bereczki D; Semmelweis University, Budapest, Hungary.
  • Kasner SE; Hospital of the University of Pennsylvania, Philadelphia, PA, USA.
  • Lutsep HL; Oregon Health and Science University, Portland, OR, USA.
  • Tsivgoulis G; National and Kapodistrian University of Athens, Attikon University Hospital, Athens, Greece.
  • Ntaios G; University of Thessaly, Larissa,Greece.
  • Czlonkowska A; Institute of Psychiatry and Neurology, Warsaw, Poland.
  • Shuaib A; University of Alberta Hospital, Edmonton, Alberta, Canada.
  • Amarenco P; University of Paris, Bichat Hospital, Paris, France.
  • Endres M; Department Neurology and Center for Stroke Research Berlin, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Diener HC; University Duisburg-Essen, Essen, Germany.
  • Gailani D; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Kahl A; Bristol Myers Squibb, Princeton, NJ, USA.
  • Donovan M; Bristol Myers Squibb, Princeton, NJ, USA.
  • Perera V; Bristol Myers Squibb, Princeton, NJ, USA.
  • Li D; Bristol Myers Squibb, Princeton, NJ, USA.
  • Hankey GJ; The University of Western Australia, Perth, Australia; Perron Institute for Neurological and Translational Science, Perth, Australia.
J Stroke Cerebrovasc Dis ; 31(10): 106742, 2022 Oct.
Article en En | MEDLINE | ID: mdl-36037679

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia / Ataque Isquémico Transitorio / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Stroke Cerebrovasc Dis Asunto de la revista: ANGIOLOGIA / CEREBRO Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tromboembolia / Ataque Isquémico Transitorio / Accidente Cerebrovascular / Accidente Cerebrovascular Isquémico Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Stroke Cerebrovasc Dis Asunto de la revista: ANGIOLOGIA / CEREBRO Año: 2022 Tipo del documento: Article